Huilan Yao
Publications by Year
Research Areas
Immune cells in cancer, Cancer, Hypoxia, and Metabolism, Cancer Research and Treatments, Acute Myeloid Leukemia Research, Epigenetics and DNA Methylation
Most-Cited Works
- → H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers(2018)500 cited
- → Up-Regulation of Mitochondrial Activity and Acquirement of Brown Adipose Tissue-Like Property in the White Adipose Tissue of Fsp27 Deficient Mice(2008)262 cited
- → Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A(2013)225 cited
- → Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms(2021)172 cited
- → Biodegradation studies of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate)(2004)143 cited
- → Results of a Clinical Trial of H3B-8800, a Splicing Modulator, in Patients with Myelodysplastic Syndromes (MDS), Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML)(2019)89 cited
- → Polycomb- and REST-associated histone deacetylases are independent pathways toward a mature neuronal phenotype(2014)52 cited
- → Corepressor Rcor1 is essential for murine erythropoiesis(2014)33 cited
- → The Corepressor Rcor1 Is Essential for Normal Myeloerythroid Lineage Differentiation(2015)33 cited
- → SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia(2021)11 cited